IFNG and cancer: MHC class II expression in cancer cells, in many cases a byproduct of effective IFN-gamma signaling [76], correlates with a better prognosis [77] and is a positive predictive factor of ICI response in many cancer types [76,78,79,80,81], including BC [82,83].